For IP professionals
This is the portal for professionals working in the field of intellectual property. Here you'll find direct access to all necessary resources.
Quick links
Extending protection for medicinal products tested on children
Pharmaceutical companies can extend the protection period of an authorised medicinal product by up to a further five years after the expiry of the patent with a supplementary protection certificate (SPC). In addition, they can extend protection for a further six months (where necessary) if they have carried out paediatric studies for a medicinal product (known as a paediatric extension).
The six-month extension can be obtained in one of two ways:
- either by extending an already granted conventional SPC, or if no conventional SPC exists...
- with a paediatric SPC, which is directly linked to the term of the patent.
Documents & links
- Background information on the introduction of paediatric extensions
- Swissmedic, Swiss Agency for Therapeutic Products – medicines for children
- Patent Examination Guidelines in German
- Patent Examination Guidelines in French
- Application for the grant of a paediatric supplementary protection certificate (in German)
- Application for the grant of a paediatric supplementary protection certificate (in French)
- Application for the grant of a paediatric supplementary protection certificate (in Italian)
- Application for the extension of a supplementary protection certificate for medicinal products (in German)
- Application for the extension of a supplementary protection certificate for medicinal products (in French)
- Application for the extension of a supplementary protection certificate for medicinal products (in Italian)
News
14.05.2025 | Media release, Law and policy, News
Simplified destruction of counterfeits in small consignments
...more
30.04.2025 | Patents, Media release, Law and policy
Patents Ordinance to be adapted and modernised in line with revised Patents Act
...more
24.02.2025 | Media release
Federal Council elected Vincenza Trivigno to the IPI’s Institute Council
...more